DRUG
Bright Minds Biosciences Inc
NASDAQ: DRUG · HEALTHCARE · BIOTECHNOLOGY
$89.11
+0.13% today
Updated 2026-04-29
Market cap
$872.62M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.02
Dividend yield
—
52W range
$23 – $124
Volume
0.2M
Bright Minds Biosciences Inc (DRUG) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-42009.00 | $-288392.00 | $-7.32M | $-13.59M | $-7.02M | $-1.85M | $-8.69M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $5.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | — | $161300.00 | $880615.00 | $875056.00 | $1.15M | $839771.00 | $3.18M |
| Free cash flow | $-42009.00 | $-288392.00 | $-7.32M | $-13.59M | $-7.02M | $-1.85M | $-8.69M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |